HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hyphema: diagnosis and management.

Abstract
The management of traumatic hyphema has been controversial for many years. Treatments designed to prevent secondary hemorrhage have been proposed in the literature, then later abandoned when prospective studies failed to support them. In the last several years, published studies have demonstrated the efficacy of antifibrinolytic agents in the prevention of secondary hemorrhages. These studies have left unanswered some questions, however, such as whether antifibrinolytics are as effective in children as adults, in white patients as black, and in patients with normal hemoglobin as well as those with sickle cell hemoglobinopathies. The successful treatment of patients with hyphemas hinges on identification of risk factors, proper medical management and prompt surgical intervention when medical therapy fails.
AuthorsJ D Gottsch
JournalRetina (Philadelphia, Pa.) (Retina) Vol. 10 Suppl 1 Pg. S65-71 ( 1990) ISSN: 0275-004X [Print] United States
PMID2191385 (Publication Type: Journal Article, Review)
Topics
  • Eye Hemorrhage (etiology, prevention & control)
  • Eye Injuries (complications)
  • Hospitalization
  • Humans
  • Hyphema (complications, diagnosis, etiology, therapy)
  • Intraocular Pressure
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: